e-learning
resources
Virtual 2021
07.09.2021
Remote monitoring of respiratory patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Initial observed improvement in medication adherence maintained during the COVID-19 pandemic in asthma and COPD
L. Kaye (San Francisco, United States of America), J. Nagano (San Francisco, United States of America), V. Vuong (San Francisco, United States of America), M. Barrett (San Francisco, United States of America), M. Barrett (San Francisco, United States of America)
Source:
Virtual Congress 2021 – Remote monitoring of respiratory patients
Session:
Remote monitoring of respiratory patients
Session type:
Oral Presentation
Number:
3942
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Kaye (San Francisco, United States of America), J. Nagano (San Francisco, United States of America), V. Vuong (San Francisco, United States of America), M. Barrett (San Francisco, United States of America), M. Barrett (San Francisco, United States of America). Initial observed improvement in medication adherence maintained during the COVID-19 pandemic in asthma and COPD. 3942
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Medication adherence in high exacerbation risk groups of COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Predictors for adherence to COPD exacerbation action plans
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018
COPD exacerbations and adherence to treatment improvement:what goal can be achieved?
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
Patterns of symptom change measured using the EXACT diary associated with prescription of corticosteroids or antibiotics in COPD exacerbations
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Does influenza vaccination increase consultations for corticosteroid prescriptions or exacerbations of asthma or chronic obstructive pulmonary disease?
Source: Annual Congress 2003 - COPD: risk factors and course of disease
Year: 2003
Symptom pattern and treatment for people non-compliant with asthma medication
Source: Annual Congress 2005 - Allergic rhinitis and asthma in primary care
Year: 2005
Effectiveness of pharmacist intervention for asthma control improvement
Source: Eur Respir J 2008; 31: 790-799
Year: 2008
Association of COPD inhaled medication adherence with hospitalization for acute exacerbation of COPD (AECOPD)
Source: International Congress 2017 – COPD management
Year: 2017
Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
The profile of poor ICS adherence in uncontrolled moderate to severe asthma.
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Differences between asthmatics and nonasthmatics hospitalised with influenza A infection
Source: Eur Respir J 2013; 41: 824-831
Year: 2013
Tiotropium reduces asthma exacerbations in asthmatic patients with persistent airflow obstruction uncontrolled despite treatment in accordance with guidelines
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012
Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Compliance of inhalation medication in relation to illness perception, quality of life and predicted pulmonary function in COPD patients
Source: Annual Congress 2010 - Advances in lung function II
Year: 2010
Budesonide/formoterol for maintenance and relief in adolescents with asthma: fewer exacerbations and improved asthma control
Source: Eur Respir J 2004; 24: Suppl. 48, 164s
Year: 2004
Patient-reported versus objective adherence and exacerbation rates in severe asthma.
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020
Effectiveness of an educational intervention in order to improve adherence in COPD and asthma ambulatory patients.
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
The relationship between symptom scores and medication adherence in stable COPD patients
Source: International Congress 2017 – COPD management
Year: 2017
The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 240s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept